Background This study determined the family history and clinical features that suggested autosomal recessive rather than X-linked Alport syndrome. Methods All patients had the diagnosis of Alport syndrome and the mode of inheritance confirmed by genetic testing, and underwent examination at a single centre. Results Patients comprised 9 males and 6 females with autosomal recessive Alport syndrome, and 18 males and 22 females with X-linked disease. Fourteen (93 %) individuals with autosomal recessive Alport syndrome developed early end-stage renal failure, all 15 had hearing loss, and most had lenticonus (12, 80 %), and a central (13, 87 %) or peripheral (13, 87 %) retinopathy. These features occurred as often as in males with X-linked disease. Females with autosomal recessive inheritance were less likely to have an affected family member in another generation (p =0.01) than females with Xlinked disease. They were more likely to have renal failure (p =0.003), hearing loss (p =0.02) and lenticonus (p <0.001). Fifty percent had a central retinopathy compared with 18 %
Introduction
Alport syndrome is characterised by hematuria, progressive renal failure, hearing loss, lenticonus, perimacular flecks and a peripheral coalescing retinopathy [1, 2] . X-linked inheritance accounts for 85 % of patients [3] and is caused by mutations in the COL4A5 gene [4] . Most other patients have autosomal recessive disease with two mutations, one on each allele (in trans) affecting either the COL4A3 or COL4A4 gene [5] . Lenticonus and the central or peripheral retinopathy are found with both forms of inheritance [6] .
The distinction between X-linked and autosomal recessive inheritance is important because of the very different risks for other family members of being affected and, in particular, of developing end-stage renal failure. In X-linked Alport syndrome, the low de novo mutation rate (12 % ) [7] means that most affected individuals inherit a mutation from a parent, and that other family members (siblings, grandparents, uncles, cousins) may also be affected. An affected male does not transmit the disease to any of his sons, but all his daughters inherit the mutation. An affected female transmits the mutation to half of her sons and half of her daughters. X-linked disease appears to skip a generation where a female carrying a mutation is undiagnosed.
In contrast, the parents and offspring of individuals with autosomal recessive Alport syndrome have hematuria, but renal failure is uncommon, and when it does occur, often results from coincidental renal disease. Parents and offspring do not develop extrarenal features because they have only a single copy of the disease-causing mutation. Most have the diagnosis of thin basement membrane nephropathy [8] . The risk for the siblings of an individual with autosomal recessive Alport syndrome of inheriting both mutations and developing renal failure is 25 %.
The distinction between X-linked and autosomal recessive Alport syndrome has become easier with the widespread adoption of genetic testing. Mutation detection rates have also improved, especially using a combination of direct sequencing and techniques that identify large deletions, insertions or rearrangements [9] . However, each of the genes mutated in Alport syndrome is enormous and testing is expensive, so it is helpful to indicate the likely mode of inheritance when requesting genetic analysis.
There are often clues to the mode of inheritance from the family pedigree, clinical examination and other investigations. X-linked Alport syndrome is more likely in cases where disease occurs in multiple generations, where males are affected more severely than females, and where the glomerular and epidermal membranes lack the collagen IV α5 chain [10, 11] . Autosomal recessive inheritance is suspected where there is no family history of Alport syndrome or renal failure, a female develops renal failure [12] , both parents have hematuria, and the glomerular basement membrane (GBM) lacks the collagen IV α5 chain but this persists in the skin [13] . Autosomal recessive inheritance is also suspected when Alport syndrome occurs in the offspring of a consanguineous marriage.
However it is not always possible to deduce the mode of inheritance, for example, where there is no family history of Alport syndrome or renal failure because of de novo mutations, families are small, or affected individuals are young or do not have the typical phenotype.
In this study we reviewed a cohort of individuals from a single centre in whom the diagnosis of Alport syndrome and its mode of inheritance were confirmed with genetic testing. Our aim was to determine how well clinical features differentiated recessive from X-linked inheritance.
Methods
Patients were recruited from those attending the inherited renal disease clinics at Austin Health or Northern Health between 1995 and 2012. They were suspected to have Alport syndrome on the basis of GBM lamellation in a renal biopsy performed on themselves or another affected family member [14] .
The diagnosis of Alport syndrome and mode of inheritance were confirmed with genetic testing. Mutations were demonstrated by genomic or cDNA sequencing in the laboratories at Northern Health or at Guy's and St Thomas' Hospital Trust using methods described previously [15] . Autosomal recessive disease was diagnosed when patients had two pathogenic mutations in the COL4A3 or COL4A4 gene, and X-linked disease when they had a single pathogenic COL4A5 mutation.
All individuals were examined clinically by the same renal physician (JS) and ophthalmologist (DC). Hearing loss was self-reported, but in some cases audiometry was performed. All individuals were studied for ocular abnormalities without the ophthalmologist being aware of disease status. Patients were examined for the oil droplet sign of anterior lenticonus using a hand-held retinoscope and their pupils dilated with 1 % tropicamide (Minims; Bausch & Lomb, Rochester, NY) and their optic fundi examined for the central and peripheral retinopathies by direct ophthalmoscopy, slit lamp biomicroscopy with a 78D lens and by indirect ophthalmoscopy with a 20D lens. The peripheral retina was defined as being at least 2 optic disc diameters from the foveola. All patients also underwent retinal photography of both optic fundi with one view centred on the foveola and another on the optic disc (KOWA non-mydriatic camera; KOWA Corp., Osaka, Japan).
This study had the approval of the Human Research Ethics Committee of Austin Health and Northern Health, and all patients provided signed informed consent.
Statistical analysis
Categorical data were compared using Fisher's exact test and continuous data with the t test (GraphPad Software Inc., San Diego, CA).
Results

Autosomal recessive Alport syndrome
Fifteen patients (9 male, 6 female) were identified from ten families with autosomal recessive Alport syndrome (Tables 1  and 2 ). Three families (30 %) had multiple affected individuals (siblings in two, cousins in one) ( Table 1 ). The affected cousins shared a common mutation, but each also had another, different mutation. All affected relatives were in the same generation.
Two affected individuals were from consanguineous families and both had homozygous mutations. A further individual also had a homozygous mutation although her parents were not known to be related.
Eight of the families (80 %) had at least one nonsense mutation, and overall nonsense mutations accounted for 12 of the 20 (60 %) mutations.
Fourteen (93 %) patients had developed renal failure prior to examination, and the other patients had hematuria and proteinuria but normal renal function (Table 2) . Eight (53 %) had end-stage renal failure before the age of 30 years, and their overall average age at renal failure onset was 27.2±6.6 years. Most patients had hearing loss (15 patients, 100 %), lenticonus (12, 80 %) and central (13, 87 %) and peripheral (13, 87 %) retinopathies.
X-linked Alport syndrome
Forty patients (18 male, 22 female) were identified from 24 families with X-linked Alport syndrome (Tables 1, 2 ). Males and females were examined in eight families. One female was from a large family with three examples of consanguinity, including her parents, but she had a single COL4A5 mutation and hence X-linked disease.
Overall, 19 (79 %) families had more than one affected member. Of the 14 families where the index case was male, 13 (93 %) had another affected individual. Of the 17 families where the index case was female, 14 (82 %) had another affected individual. Three males and 11 females (13/24 families, 54 %) had a relative with renal failure in another generation.
Five families (36 %) had a pathogenic nonsense mutation, and overall nonsense mutations accounted for five of the 18 (28 %) mutations.
Fourteen males (78 %) with X-linked disease had developed renal failure, 12 (67 %) before the age of 30 years, and their overall average age at onset of renal failure was 23.7± 6.6 years. Seventeen had hearing loss (94 %), ten (56 %) had lenticonus, 11 (59 %) had a central retinopathy and 12 (83 %) had a peripheral retinopathy.
Females with X-linked disease developed end-stage renal failure uncommonly (1 patient, 5 %), eight (36 %) had hearing loss, none had lenticonus, four (18 %) had a central retinopathy and seven (35 %) had a peripheral retinopathy.
Autosomal recessive disease and X-linked disease in males
Patients with autosomal recessive disease were less likely to have an affected relative with renal failure than those with X-linked disease (3/10, and 13/14, p=0.002) ( Table 1) . They were also less likely to have an affected relative in another generation than those with X-linked disease (0/10 and 13/24, p=0.005).
Patients with autosomal recessive disease were more likely to have a nonsense mutation (or a mutation producing a downstream stop codon) (80 % and 36 %, p=0.047), and nonsense mutations were more common than in X-linked disease (60 % and 28 %, p=0.06). Males and females with autosomal recessive Alport syndrome were just as likely to have the typical clinical features as males with X-linked disease (Table 2 ). In particular, renal failure, lenticonus and the central retinopathy were very common with both X-linked and recessive inheritance.
Autosomal recessive disease in females and X-linked disease in females
Females with autosomal recessive disease were less likely to have an affected male relative than females with X-linked disease (17 vs. 65 %, respectively; p =0.07) ( Table 2 ). They were also less likely to have a relative with renal failure in another generation (0 vs. 65 %, respectively; p =0.01).
Females with autosomal recessive disease were more likely to develop renal failure (5 vs. 83 %, respectively, p =0.0004), and to develop renal failure before the age of 30 years (5 vs. 67 %, respectively, p =0.003) than females with X-linked disease. They were also more likely to have a self-reported hearing loss (100 vs. 36 %, respectively, p =0.02) and lenticonus (67 vs. 0 %, respectively p <0.001). The central retinopathy occurred in 50% of females with recessive and 18 % with X-linked disease (p =0.14). There was no difference in the likelihood of a peripheral retinopathy [50 (autosomal recessive) vs. 35 % (X-linked), p =0.63].
In this series, females with recessive disease were more likely to have a nonsense mutation, (or changes producing a downstream stop codon) (29 vs. 83 %, respectively, p =0.05) and there was a trend for an increase in nonsense compared with other mutations (29 vs. 67 %, respectively, p =0.07) ( Table 2) .
Discussion
Autosomal recessive Alport syndrome is less common than X-linked disease, but the distinction between these forms of inheritance is important because of their different clinical implications, especially the risk of renal renal failure, for other family members. This study indicates an increased risk of recessive inheritance in cases where the disease affects only one generation and where females have renal failure, hearing loss, lenticonus or central retinopathy.
This cohort represents about one-third of our families with Alport syndrome and includes all of those individuals who had been fully clinically assessed and in whom the causative mutations were known. The major strengths of the study are that the patients were examined by the same clinicians at a single centre and had undergone retinal imaging, and that both the disease and mode of inheritance were confirmed genetically.
Autosomal recessive Alport syndrome may be suspected from the family pedigree. In this study, all individuals with recessive inheritance were members of the same generation. In contrast, more than half of the families with X-linked disease had a member with renal failure in another generation. However, examination of the pedigree may also be misleading. Thus, one of our families with proven X-linked disease included three consanguineous marriages, including the parents of an affected female with renal failure. Another individual with recessive disease was homozygous for an unusual mutation but was not from a known consanguineous family. Finally, one family included the two affected sons of maternal cousins, which suggested X-linked inheritance, but the sons shared a COL4A4 mutation with each also having a second different COL4A4 variant, consistent with recessive disease. This study confirmed that recessive Alport syndrome presents in teenagers or adults more often than in children [12] . Overall, in our patient cohort the risk of renal failure onset before the age of 30 years was the same for patients with autosomal recessive as for those with X-linked Alport syndrome. Only 5 % of our females with X-linked disease developed renal failure, which is fewer than described elsewhere [16] and probably reflects our patients' younger age and our practice of screening members of the extended family. However, renal failure onset before the age of 30 years was more common in females with autosomal recessive Alport syndrome than in those with X-linked disease.
Hearing was assessed mainly by clinical questioning. All five females, aged 48-60 years, with X-linked Alport syndrome, who underwent formal audiometry had the typical high-frequency hearing loss, suggesting hearing loss is common in older affected females.
Although all our participants underwent ophthalmological examination and retinal imaging, the retina could not always be visualised adequately because of cataract. Among our patients, both lenticonus and central retinopathy were very common in males and females with recessive Alport syndrome, but not in females with X-linked disease. Peripheral retinopathy was equally prevalent in both forms of inheritance and did not distinguish between them.
In this study, nonsense mutations were twice as common in individuals with recessive Alport syndrome, overall, and in females, compared with X-linked disease. In X-linked Alport syndrome, nonsense mutations are associated with a more severe phenotype, characterised by early onset renal failure and extrarenal manifestations [7, 14, 17] . It is not clear whether nonsense mutations were increased in our patient cohort because they had more extrarenal Alport features. Only one of our patients with recessive disease had no nonsense mutation and her disease was mild. By the age of 32 years, she had hematuria and proteinuria but not renal impairment or ocular abnormalities. There are few data on genotype-phenotype correlations in autosomal recessive disease, and our patients with their mainly nonsense mutations may have had a correspondingly worse phenotype than is generally found.
In conclusion, clinical features in individuals with autosomal recessive Alport syndrome resemble those in males with X-linked disease, and females with autosomal recessive inheritance are more likely to have early onset renal failure, hearing loss, lenticonus and, possibly, the central retinopathy than those with X-linked disease. Further studies will indicate whether nonsense mutations are associated with a worse phenotype than missense mutations in recessively inherited disease.
